People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Turnpoint Medical Devices, Inc. | — | Biotechnology | Series A | $9.6M | $3.6M | 2017 |
Douglas J. Hulse at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas J. Hulse on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joerg Klaube | 1 | 3 |
| George Boyajian | 1 | 3 |
| Christopher York | 1 | 2 |
| Jerry C. Ruddle | 1 | 2 |
| Joerg H. Klaube | 1 | 2 |
| Mark J. Goran | 1 | 1 |
| Christopher J. York | 1 | 1 |
| Richard F. Worthen | 1 | 1 |
| Douglas C. Hulse | 1 | 1 |
| Jerry Ruddle | 1 | 1 |
| John Ruddle | 1 | 1 |
| John Toedtman | 1 | 1 |
| Douglas Hulse | 1 | 1 |
| Joerge Klaube | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.